CraniUS Therapeutics Closes $20 Million Series B Round to Advance NeuroPASS™ Platform Towards Future Commercialization ...Middle East

Enabling Direct Therapeutic Access Beyond the Blood-Brain Barrier BALTIMORE, Jan. 28, 2026 /PRNewswire/ -- CraniUS Therapeutics LLC, a privately held neurotechnology company, today announced it has raised $20 million in Series B financing to accelerate development of NeuroPASS™, a fully...

Hence then, the article about cranius therapeutics closes 20 million series b round to advance neuropass platform towards future commercialization was published today ( Wednesday 28/01/2026 - 03:51 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( CraniUS Therapeutics Closes $20 Million Series B Round to Advance NeuroPASS™ Platform Towards Future Commercialization )

Also on site :

• Who Is Anthony Kazmierczak? Ilhan Omar Attack Suspect Identified
• Bobby Bones Is Barely Recognizable After Rescuing a Stranger During Winter Storm Fern
• 2000s Heavy Metal Band Aims for ‘Suspended Illusion’ on Its 20th Anniversary Tour